1096P Camrelizumab Plus Apatinib in Patients with Advanced Mucosal Melanoma: A 3-Year Survival Update with Biomarker Analysis
Annals of Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined